Table 4 Antimicrobial sensitivity pattern among the studied pneumonia children
Sensitivity | Type | |
|---|---|---|
CAP (n = 30) | HAP (n = 20) | |
Clindamycin | 4 (13.3%) | 1 (.0%) |
Colistin (Colistimethate Sodium) | 5 (16.7%) | 18 (90.0%) |
Co-trimoxazole | 9 (30.0%) | 1 (5.0%) |
Vancomycin | 10 (33.3%) | 1 (5.0%) |
Linezolid | 15 (50.0%) | 1 (5.0%) |
Piperacillin-Tazobactam | 4 (13.3%) | 2 (0.0%) |
Azithromycin | 6 (20.0%) | 0 (0.0%) |
Clarithromycin | 1 (3.3%) | 0 (0.0%) |
Ampicillin-Sulbactam | 6 (20.0%) | 3 (15.0%) |
Amoxicillin-Clavulanic acid | 4 (13.3%) | 0 (0.0%) |
Amikacin | 2 (6.7%) | 7 (35.0%) |
Gentamicin | 2 (6.7%) | 5 (5.0%) |
Cefepime | 9 (30.0%) | 2 (0.0%) |
Cefoprazone | 7 (23.3%) | 2 (0.0%) |
Ceftriaxone | 9 (30.0%) | 0 (0.0%) |
Cefotaxime | 8 (26.7%) | 0 (0.0%) |
Ceftazidime | 6 (0.0%) | 1 (5.0%) |
Cefadroxil | 4 (13.3%) | 0 (.0%) |
Cefuroxime | 1 (3.3%) | 1 (5.0%) |
Ciprofloxacin | 10 (3.3%) | 5 (25.0%) |
Levofloxacin | 11 (6.7%) | 5 (25.0%) |
Meropenem | 3 (10.0%) | 1 (5.0%) |
Imipenem-Cilastatin | 3 (10.0%) | 4 (20.0%) |
Tigecycline | 4 (3.3%) | 10 (50.0%) |
Teicoplanin | 5 (16.7%) | 0 (0.0%) |